skip to main content

Neisseria flavescens

Neisseria flavescens

Catalogue No.

NCTC 3191

Current Name

Neisseria flavescens

Type Strain

Reference Strain

Original Strain Reference

156

Culture Conditions

Growth Conditions on Solid Media

Chocolate blood agar, 37°C, O₂

Biological and Genomic Info

Gram Stain Result

Negative

Oxidation

D-sorbitol: -

D-sucrose: -

Enzyme Tests

Beta-galactosidase: -

Lecithinase / alpha: -

Strain Data

(ATCC 13119) S. E. Branham, NIH Maryland in 1932 / Meningitis / Branham, S. E. (1930) Publ. Hlth. Rep., Wash. 45, 845

Colony Appearance

Smooth, Shiny

Additional Info

Accession Date

01/01/1932

Depositor

BRANHAM S E

Isolated From

human, meningitis

History

ISOLATED BY BRANHAM S E NAT HEALTH INST MARYLAN

Previous Catalogue Name

Neisseria flavescens

Applications

Bibliography

BRANHAM S E 1930 PUBL HLTH REP WASH 45 845

Available Formats

  • Ampoule (Bacteria)

If use of this culture results in a scientific publication, it should be cited in the publication as: Neisseria flavescens (NCTC 3191)

It is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

The Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by Culture Collections are accurate, Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.